Results 1 to 10 of about 38,893 (219)
European Psychiatry, 2023 Introduction Studies consistently show that patients with prescription opioid use disorder (OUD) respond to buprenorphine treatment. Few studies have followed these patients in the long-term.
R. Weiss, M. L. Griffin
doaj +1 more source
Opioid Substitution: More than Only Methadone!
European Psychiatry, 2022 Opioid misuse and its rising rates of morbidity and associated mortality is an increasing area of concern worldwide. The licit/illicit consumption of opioids ranging from plant-based substances and pharmaceutical drugs (particularly analgesia) to the new
M. Torrens
doaj +1 more source
Substance Abuse Treatment, Prevention, and Policy, 2022 Background Concurrent opioid and stimulant use is on the rise in North America. This increasing trend of use has been observed in the general population, and among people released from prison in British Columbia (BC), who face an elevated risk of ...
Heather Palis +6 more
doaj +1 more source
BMJ Open, 2021 Objective To describe opioid agonist treatment prescribing rates in provincial prisons and compare with community prescribing rates.Design We used quarterly, cross-sectional data on the number and proportion of people prescribed opioid agonist treatment ...
Fiona Kouyoumdjian +4 more
doaj +1 more source
Harm Reduction Journal, 2021 Background For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid analgesic) and diacetylmorphine ...
Heather Palis +3 more
doaj +1 more source
International Journal of Population Data Science, 2022 Objectives There are critical periods of mortality risk at onset and cessation of opioid agonist treatment. We aim to determine whether non-fatal overdose followed the same pattern as fatal overdose, comparing the first 4 weeks of treatment and ...
Nicola Jones +6 more
doaj +1 more source
Harm Reduction Journal, 2020 Background Due to the high prevalence of mental disorders among people with opioid use disorder, the objective of this study was to determine the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention ...
Kristen A. Morin +6 more
doaj +1 more source
Drug and Alcohol Dependence Reports, 2023 Background: Among people who inject drugs, frequent injecting and experiencing withdrawal are associated with facilitating others’ first injections. As these factors may reflect an underlying substance use disorder, we investigated whether first-line ...
Zachary Bouck +9 more
doaj +1 more source
Interim opioid agonist treatment for opioid addiction: a systematic review
Harm Reduction Journal, 2022 Background Opioid use disorder is a public health problem and treatment variability, coverage and accessibility poses some challenges. The study’s objective is to review the impact of interim opioid agonist treatment (OAT), a short-term approach for ...
Laura Samsó Jofra +3 more
doaj +1 more source
Substance Abuse Treatment, Prevention, and Policy, 2019 Objective The objective was to characterize the relationship between geography, concurrent psychiatric services, all-cause mortality, and acute health care use for individuals enrolled in Opioid Agonist Treatment, in Ontario, Canada. Methods We conducted
Kristen A. Morin +7 more
doaj +1 more source